Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72026 - 72050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	OSBP2	23762	upregulated	Silicon Dioxide analog results in increased expression of OSBP2 mRNA	22q12.2	A24195
Silicon dioxide	Approved	OSBPL5	114879	downregulated	Silicon Dioxide analog results in decreased expression of OSBPL5 mRNA	11p15.4	A24195
Silicon dioxide	Approved	OSCAR	126014	downregulated	Silicon Dioxide analog results in decreased expression of OSCAR mRNA	19q13.42	A24194
Silicon dioxide	Approved	OSGIN1	29948	upregulated	Silicon Dioxide results in increased expression of OSGIN1 mRNA	16q23.3	A24197 A24196
Silicon dioxide	Approved	OSM	5008	upregulated	Silicon Dioxide analog results in increased expression of OSM mRNA	22q12.2	A24194
Silicon dioxide	Approved	OSMR	9180	upregulated	Silicon Dioxide analog results in increased expression of OSMR mRNA	5p13.1	A24195
Silicon dioxide	Approved	OSR1	130497	upregulated	Silicon Dioxide analog results in increased expression of OSR1 mRNA	2p24.1	A24195
Silicon dioxide	Approved	OSR2	116039	downregulated	Silicon Dioxide analog results in decreased expression of OSR2 mRNA	8q22.2	A24195
Silicon dioxide	Approved	OTOP3	347741	downregulated	Silicon Dioxide analog results in decreased expression of OTOP3 mRNA	17q25.1	A24195
Silicon dioxide	Approved	OTUB2	78990	upregulated	Silicon Dioxide analog results in increased expression of OTUB2 mRNA	14q32.12	A24195
Silicon dioxide	Approved	OTUB2	78990	upregulated	Silicon Dioxide results in increased expression of OTUB2 mRNA	14q32.12	A24196
Silicon dioxide	Approved	OTX1	5013	downregulated	Silicon Dioxide analog results in decreased expression of OTX1 mRNA	2p15	A24195
Silicon dioxide	Approved	OVGP1	5016	downregulated	Silicon Dioxide analog results in decreased expression of OVGP1 mRNA	1p13.2	A24195
Silicon dioxide	Approved	OVOL1	5017	upregulated	Silicon Dioxide analog results in increased expression of OVOL1 mRNA	11q13.1	A24194
Silicon dioxide	Approved	OVOL1	5017	upregulated	Silicon Dioxide results in increased expression of OVOL1 mRNA	11q13.1	A24196
Silicon dioxide	Approved	OVOL2	58495	downregulated	Silicon Dioxide analog results in decreased expression of OVOL2 mRNA	20p11.23	A24195
Silicon dioxide	Approved	OXCT1	5019	upregulated	Silicon Dioxide analog results in increased expression of OXCT1 mRNA	5p13.1	A24195
Silicon dioxide	Approved	OXR1	55074	downregulated	Silicon Dioxide analog results in decreased expression of OXR1 mRNA	8q23.1	A24195
Silicon dioxide	Approved	OXTR	5021	upregulated	Silicon Dioxide analog results in increased expression of OXTR mRNA	3p25.3	A24194
Silicon dioxide	Approved	OXTR	5021	upregulated	Silicon Dioxide results in increased expression of OXTR mRNA	3p25.3	A24196
Silicon dioxide	Approved	P2RX5	5026	upregulated	Silicon Dioxide analog results in increased expression of P2RX5 mRNA	17p13.2	A24195
Silicon dioxide	Approved	P2RX7	5027	downregulated	Silicon Dioxide analog results in decreased expression of P2RX7 mRNA	12q24.31	A24194
Silicon dioxide	Approved	P2RY1	5028	upregulated	Silicon Dioxide analog results in increased expression of P2RY1 mRNA	3q25.2	A24194
Silicon dioxide	Approved	P2RY1	5028	downregulated	Silicon Dioxide results in decreased expression of P2RY1 mRNA	3q25.2	A24196
Silicon dioxide	Approved	P2RY10	27334	upregulated	Silicon Dioxide analog results in increased expression of P2RY10 mRNA	Xq21.1	A24195

Displaying entries 72026 - 72050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability